Aging and Cancer Effects (ACE) Study

Study summary

Hypotheses: 1. Subjective self-reported data can be used to accurately reflect functioning across the 5 key domains. 2. Cancer and its various treatment modalities will exert detrimental effects on the 5 key domains in older adults with cancer. 3. Some aspect of baseline patient characteristic will be predictive of cancer-related outcomes.

Ask AI to explain this study

Start here

Key things to know

Main goalNot specified

This describes the study’s primary purpose.

What is being studiedNot specified

The study team can explain what participation involves.

Who it may be forBreast Cancer · Lung Cancer

These are broad labels—not an eligibility decision.

Checked against the public recordLast updated Oct 5, 2015 · Source: ClinicalTrials.gov

Is enrollment open?Completed

Ask the study team to confirm whether enrollment is open.

What kind of study?Not applicable

Observational

Where is it offered?1 U.S. location

Locations may change over time.

Who runs it?University of Wisconsin, Madison

Study sponsor

Study overview

What this study is about

Purpose: Not specified
Study type: Observational
Phase: Not applicable
Sponsor: University of Wisconsin, Madison
Interventions being studied: Not specified

Explore related studies

How this study is categorized

These labels come from structured fields and exact terms in the public record.

Public criteria

Who may be able to participate

The sponsor separates these requirements into two groups. You do not need to interpret them alone—use them to guide a conversation with the study team.

Requirements people may need to meetInclusion criteria

Willing to do memory testing
Willing to participate in activities of daily living assessment
Can use a cane or walker
Willing to complete a balance performance assessment, if able.

Reasons someone may not be able to joinExclusion criteria

Currently receiving treatment for cancer.
Has a previous history of brain cancer
Significant neurological disease other than AD that might affect cognitive function, such as stroke, Parkinson's disease, multiple sclerosis, or serious traumatic brain injury.

Important: This is the sponsor’s public criteria, not a determination of eligibility. The study team must review your individual situation.

Study sites

U.S. locations

University of WisconsinMadison, Wisconsin

Source and freshness
Processed from ClinicalTrials.gov. Last public update: Oct 5, 2015. Always confirm current availability with the study team.

View original record ↗